Business
Attending 10th Annual HealthTech Investment Forum
Attending 10th Annual HealthTech Investment Forum.
About this update from Diaceutics Plc
[{"type":"text","content":"\n\n \n \nDiaceutics to attend 10th Annual HealthTech Investment Forum in Basel on September 19\n \nBelfast and London, 7 September 2023 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical industry, announces that management will attend and present at the 10th Annual HealthTech Investment Forum in Basel, Switzerland on 19 September, 2023. Diaceutics CEO Peter Keeling will be a speaker at the Revolution in Precision Medicine Panel: Investing in Big Data & AI.\n \nFor more information, please click here.\n \nEnquiries:\n\n\n\nDiaceutics PLC \n\n\n Tel: +44 (0)28 9040 6500\n\n\n\n\nPeter Keeling, Chief Executive Officer\nRyan Keeling, Chief Innovation Officer\nNick Roberts, Chief Financial Officer \n\n\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nStifel Nicolaus Europe Limited (Nomad & Broker)\n\n\nTel: +44 (0)20 7710 7600\n\n\n\n\nBen Maddison\n\n\n\n\n\n\n\nNick Harland\nKate Hanshaw\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAlma PR\n\n\nTel: +44 (0)20 3405 0205\n\n\n\n\nCaroline Forde\n\n\[email protected]\n\n\n\n\nMatthew Young\n\n\n\n\n\n\n\nKinvara Verdon\n\n\n\n\n\n\n \nAbout Diaceutics\n \nAt Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.\n \nWe provide the world's leading pharma and biotech companies with an end-to-end commercialization solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostic Network®.\n \n \n\n","length":6658,"tagName":"div"}]